Figure 4 : Pharmacokinetic analysis of POH-Ns. (A) Semiquantitative analysis of fluorescence due to the liver by ROI (Region of Interest) measurement (n = 3). (B) Semiquantitative analysis of fluorescence due to the kidney by ROI measurement (bottom panel) (n = 3). *p < 0.05.

Kizaka-Kondoh et al.Journal of Pharmaceutical Technology and Drug Research  2013 2:2DOI : 10.7243/2050-120X-2-2